N/A
N=69
Study of Clinic-delivered Physical Activity Referrals to Cancer Survivors
Cancer · Physical Inactivity
Bottom Line
View on ClinicalTrials.gov: NCT05216380 ↗Enrolled (actual)
69
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: The Number of Patients Referred Using the Secure Webform — 54 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- ActivityLink (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Massachusetts, Worcester
- Primary completion
- Mar 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Number of Patients Referred Using the Secure Webform |
54 | — |
| SECONDARY Proportion of Eligible Clinic Staff Who Enroll |
15 | — |
| SECONDARY Proportion of Referred Patients Who Enroll in Programs |
19 | — |
Summary
Background: Cancer survivors have a greater risk of cardiovascular disease (CVD) and have low physical activity levels. Physical inactivity is one modifiable risk factor for CVD, and increased physical activity has shown a cardioprotective effect on lowering CVD risk. The objective of ActivityLink is to use an electronic referral (e-referral) implementation program for clinic staff to refer survivors to an in-person and a virtual physical activity program.
Methods: Participants in this study will include clinic staff and patients. Investigators will first conduct interviews with clinic staff and patients, followed by usability testing of a referral system with staff. The study team will then beta-test two rounds of testing using Plan, Do, Study, Act (PDSA) Cycles for clinic staff to refer patients in the clinic. Quantitative data and qualitative interviews will be collected following each PDSA cycle, with refinements made based on feedback.
Outcomes: The proposed study addresses a critical need to implement physical activity referrals into routine cancer survivorship visits.
Eligibility Criteria
Inclusion Criteria for Aim 1a:
- Medical providers who are 1) Are a current UMass Cancer Clinic patient navigator, oncologist, radiologist, or cardiologist 2) Consent to participate in the study.
- Program leaders who are 1) In charge of implementing evidence-based physical activity program for cancer patients/survivors (LIVESTRONG at the Y); 2) Consent to participate in the study.
- Patients who receive treatments at the UMass Cancer Clinics who are 1) Are at least 18 years of age; and 2) Consent to participate in the study.
Exclusion Criteria for Aim 1a:
- Medical providers who are 1) Not currently employed at UMass Memorial Health (UMH), 2) Not involved in direct treatment of care coordination of cancer patients
- Program leaders who are 1) not involved in the implementation of an evidence-based physical activity program for cancer survivors
- Patients who are 1) Unable or unwilling to provide informed consent; 2) <18 years of age.
Inclusion Criteria for Aim 1b:
- Participants for Aim 1b are eligible if they are: 1) Are a UMass Cancer Clinic patient navigator; and 2) Consent to participate in the study.
Inclusion criteria for Aim 2:
- Clinic staff who 1) Are a current UMass Cancer Clinic staff delivering care to patients 2) Consent to participate in the study.
- Program leaders who are 1) In charge of implementing evidence-based physical activity program that clinic staff refer cancer patients/survivors to (LIVESTRONG at the Y and FitCancer); 2) Consent to participate in the study.
- Patients who receive a physical activity program referral during their survivorship care planning from UMass Cancer Clinics who are 1) Are at least 18 years of age; and 2) Consent to participate in the study.
Exclusion Criteria for Aim 2:
- Clinic staff who are 1) Not currently employed at UMass, 2) Not implementing patient treatment of care coordination of cancer patients
- Program leaders who are 1) not involved in the implementation of an evidence-based physical activity program clinic staff refer cancer survivors to
- Patients who are 1) Unable or unwilling to provide informed consent; and 2) <18 years of age
Data sourced from ClinicalTrials.gov (NCT05216380). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.